Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 878 participants.

Also called NCT01676220

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 878 participants (enrolled count) (from the registry)
Sponsor
  • Sanofi Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01676220
  • EudraCT 2012-000146-35
Main results
  • New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3) Diabetes, obesity & metabolism, 2015-04 DOI, PubMed 25641260, PMC4409854 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01676220. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-09 (actual). Results posted on 2015-04-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Acronym
EDITION III
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
HOE901-U300 (new formulation of insulin glargine)
Intervention (Drug)
Lantus (insulin glargine)
Lead sponsor
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct01676220
Content hash
d26dc73a56373128f1ca54ecdd6386653f2711eb14106e8f28dc6c49ee25379b